Quidelortho CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

28 Feb 2025

QDEL

10-K: QuidelOrtho's 10-K Filing Reveals Strategic Shifts Amidst Competitive Diagnostic Market

QuidelOrtho's 2024 10-K filing highlights strategic shifts including a U.S. donor screening portfolio wind-down and responses to competitive pressures in the diagnostics market.

NASDAQ

31 Jul 2024

QDEL

Quidelortho CORP

10-K/A: QuidelOrtho Amends 2023 Annual Report to Include Additional Audit Details

QuidelOrtho Corporation files an amendment to its 2023 annual report to include additional details under Critical Audit Matters, while reaffirming its unqualified opinion on the financial statements.

NASDAQ

29 Feb 2024

QDEL

Quidelortho CORP

10-K: QuidelOrtho Corporation Navigates Post-Merger Landscape with Focus on Innovation and Global Growth

QuidelOrtho Corporation's 2023 annual report highlights a year of strategic integration following the merger, with a focus on R&D, global expansion, and navigating a changing diagnostics market.